BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10383692)

  • 21. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay.
    Kuijper A; Buerger H; Simon R; Schaefer KL; Croonen A; Boecker W; van der Wall E; van Diest PJ
    J Pathol; 2002 Aug; 197(5):575-81. PubMed ID: 12210075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
    Djordjevic B; Hanna WM
    Mod Pathol; 2008 Oct; 21(10):1238-45. PubMed ID: 18500266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroepithelial tumours of the breast-a review.
    Lerwill MF; Lee AHS; Tan PH
    Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative activity and tumor angiogenesis is closely correlated to stromal cellularity of fibroadenoma: proposal fibroadenoma, cellular variant.
    Hasebe T; Imoto S; Sasaki S; Tsubono Y; Mukai K
    Pathol Int; 1999 May; 49(5):435-43. PubMed ID: 10417687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.
    Umekita Y; Yoshida H
    Pathol Int; 1999 Sep; 49(9):807-10. PubMed ID: 10504552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
    Cimino-Mathews A; Hicks JL; Sharma R; Vang R; Illei PB; De Marzo A; Emens LA; Argani P
    Hum Pathol; 2013 Nov; 44(11):2494-500. PubMed ID: 23916291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
    Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
    J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
    Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
    Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?
    Jacobs TW; Chen YY; Guinee DG; Holden JA; Cha I; Bauermeister DE; Hashimoto B; Wolverton D; Hartzog G
    Am J Clin Pathol; 2005 Sep; 124(3):342-54. PubMed ID: 16191502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phyllodes tumours of the breast - differentiating features in core needle biopsy.
    Tsang AK; Chan SK; Lam CC; Lui PC; Chau HH; Tan PH; Tse GM
    Histopathology; 2011 Oct; 59(4):600-8. PubMed ID: 21916949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
    Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
    Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of fibroepithelial tumours of the breast.
    Badhe BA; Iyengar KR; Alva N
    Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.
    Lee AH; Hodi Z; Ellis IO; Elston CW
    Histopathology; 2007 Sep; 51(3):336-44. PubMed ID: 17727475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 protein expression and gene mutation in phyllodes tumors of the breast.
    Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
    Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
    Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology?
    Scolyer RA; McKenzie PR; Achmed D; Lee CS
    Pathology; 2001 Nov; 33(4):437-43. PubMed ID: 11827409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors.
    Tse GM; Lui PC; Scolyer RA; Putti TC; Kung FY; Law BK; Lau TS; Lee CS
    Mod Pathol; 2003 Oct; 16(10):1007-13. PubMed ID: 14559983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
    Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
    Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of Fibroadenoma to Malignant Phyllodes Tumour in a 14-Year Female.
    Faridi SH; Siddiqui B; Ahmad SS; Aslam M
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):69-71. PubMed ID: 29290198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.